Organic electroluminescent materials and devices
US-11201298-B2 · Dec 14, 2021 · US
US11390639B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11390639-B2 |
| Application number | US-201916364427-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 26, 2019 |
| Priority date | Apr 13, 2018 |
| Publication date | Jul 19, 2022 |
| Grant date | Jul 19, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A compound having a first ligand LA of Formula Iis disclosed, where Z1 to Z4 are each independently C or N; at least one of Z1 to Z4 is N; and ring A is a structure of Formula II
Opening claim text (preview).
We claim: 1. A compound comprising a first ligand L A of Formula I wherein Z 1 to Z 4 are each independently C or N; wherein at least one of Z 1 to Z 4 is N; wherein ring A is Formula II wherein each R A and R 4 independently represents mono substitution to a maximum possible number of substitutions, or no substitution; wherein Z 5 to Z 8 are each independently C or N; wherein R 3 is a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, aryl, and heteroaryl; wherein each R A and R 4 is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two substituents can be joined or fused together to form a ring; wherein R 3 and ring A do not have identical formulas; wherein the ligand L A is complexed to a metal M; wherein the compound further comprises a substituted or unsubstituted acetylacetonate ligand; and wherein the ligand L A is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand. 2. The compound of claim 1 , wherein each R A and R 4 is independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. 3. The compound of claim 1 , wherein two of Z 1 to Z 4 are N, and the remainder are C. 4. The compound of claim 1 , wherein one of Z 1 to Z 4 is N, and the remainder are C. 5. The compound of claim 1 , wherein R A represents a fused ring. 6. The compound of claim 1 , wherein Z 6 is C and is attached to an alkyl group. 7. The compound of claim 1 , wherein R 3 is a 5-membered heteroaryl group or a 6-membered aryl or heteroaryl group. 8. The compound of claim 1 , wherein M is selected from the group consisting of Os, Ir, Pd, Pt, Cu, and Au. 9. A formulation comprising the compound of claim 1 . 10. The compound of claim 1 , wherein the first ligand L A is selected from the group consisting of: wherein R 1 and R 2 are each independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof. 11. The compound of claim 1 , wherein the first ligand L A is selected from the group consisting of ligands L IV-Ai that are based on a structure of Formula IV ligands L VI-Ai that are based on a structure of Formula VI ligands L VIII-Ai that are based on a structure of Formula VIII ligands L X-Ai that are based on a structure of Formula X ligands L XII-Ai that are based on a structure of Formula XII ligands L XIV-Ai that are based on a structure of Formula XIV ligands L XVI-Ai that are based on a structure of Formula XVI and and ligands L XVIII-Ai that are based on a structure of Formula XVIII wherein i is an integer from 1 to 840 and for each i, R 1 , R 2 , R 3 , and R 4 in Formula IV, Formula VI, Formula VIII, Formula X, Formula XII, Formula XIV, Formula XVI, and Formula XVIII are defined as follows: i R 1 R 2 R 3 R 4 1. R B1 R B1 R B3 H 2. R B1 R B1 R B6 H 3. R B1 R B1 R B7 H 4. R B1 R B1 R B12 H 5. R B1 R B1 R B20 H 6. R B1 R B1 R B25 H 7. R B1 R B1 RB1 H 8. R B1 R B1 R A37 H 9. R B1 R B1 R A43 H 10. R B1 R B1 R C1 H 11. R B1 R B1 R C4 H 12. R B1 R B1 R C5 H 13. R B1 R B1 R C7 H 14. R B1 R B1 R C9 H 15. R B1 R B1
Organosilicon compounds, e.g. TIPS pentacene · CPC title
containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene · CPC title
containing four rings, e.g. pyrene · CPC title
Polycyclic condensed aromatic hydrocarbons, e.g. anthracene · CPC title
Polycyclic condensed heteroaromatic hydrocarbons · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.